CIS is First in the State to Use the Auryon Atherectomy System in a Hospital Setting to Treat Peripheral Artery Disease

Auryon Zachary

Pictured from left to right are James Pierce, RT; J’Lynn Shelby, RT; Alicia Jamie, RT; Charles Thompson, MD (back row), and Laura Peel, RN. 

ZACHARY, LA– Dr. Charles Thompson, interventional cardiologist at Cardiovascular Institute of the South (CIS), is the first in Louisiana to use the Auryon Laser Atherectomy System by AngioDynamics, Inc. in a hospital setting to treat peripheral artery disease in the legs. The procedure took place on October 30 at Lane Regional Medical Center.

The Auryon Atherectomy System uses laser technology to deliver powerful treatment for peripheral artery lesions and occlusions in the legs. It is the first laser atherectomy system to efficiently treat lesions of any type, severity, length, or location (above and below the knee), with minimal impact on vessel walls. It is the only system capable of delivering short, high-powered pulsed-laser energy to effectively treat peripheral artery disease while preserving the vessel wall.

“The ease of set up and easy tracking of the catheter makes for rapid deployment of the technology during the procedure,” said Dr. Thompson. “For the patient, this is a limb- and life-saving procedure due to the efficiency of plaque removal to open the artery.”Auryon-System-Base

Peripheral vascular disease, including artery and vein disease, affects more than 50 million people in the United States. Peripheral artery disease specifically prevents blood flow to the legs and feet, causing significant pain and limited mobility, and in severe cases, leads to the need for surgery or amputation. Symptoms of PAD in the legs include: pain or cramping after activity, numbness, coldness, sores or ulcers that won’t heal, discoloration, hair loss, shiny skin or a weak pulse.

Click here for more information on PAD. Click below to request an appointment with a CIS cardiologist. 

Photo courtesy of AngioDynamics, Inc.


About Cardiovascular Institute of the South
Founded by Dr. Craig Walker in 1983, Cardiovascular Institute of the South (CIS) is a world-leader in preventing, detecting and treating cardiovascular and peripheral vascular disease. CIS offers a comprehensive heart and vascular program with expert physicians trained in many specialties, including internal medicine, nuclear cardiology, electrophysiology, lipid management, coronary artery disease, peripheral vascular disease, structural heart and valve disease, venous disease and interventional procedures. CIS has earned international acclaim as a pioneer of research, development and education, as well as an innovator in the treatment of peripheral vascular disease. With a dedicated team of more than 1,075 team members, CIS provides comprehensive cardiovascular care at 21 locations across Louisiana and Mississippi, with 11 telemedicine programs. CIS has also been recognized by Modern Healthcare as a Best Place to Work in Healthcare for three years in a row. CIS remains at the forefront of technology, providing the highest-quality, compassionate care. This mission has guided the institute for 40 years of excellence. For more information about CIS, call 1-800-425-2565 or visit

About Lane Regional Medical Center

At Lane Regional Medical Center, we value community and take pride in the role we play as caregivers. It is an honor to say that we serve as the primary healthcare resource for approximately 200,000 of our neighbors located throughout Zachary and the surrounding region of Baker, Central, Clinton, Jackson, St. Francisville, New Roads, North Baton Rouge, and Southern Mississippi.

Lane began as a community hospital in 1960. Over the years, we evolved into a 131-bed healthcare system by continually expanding and adding new capabilities and technologies. Offering a full range of inpatient and outpatient diagnostic services, Lane supports Interventional Cardiology, Medical & Radiation Oncology, OB/GYN, Gastroenterology, General Surgery, Pediatrics, Dermatology, Wound Care and Hyperbarics, as well as Orthopedics, Labor & Delivery, In-Patient Rehabilitation, Home Health, Family Medicine, Outpatient Therapy, Emergency Services and After-Hours Urgent Care. With more than 850 dedicated team members, Lane is the largest employer within the city of Zachary. The hospital continues to grow and invest in the community by recruiting new physician specialists and providing access to exceptional healthcare services, technologies and programs. Lane’s mission is to provide exceptional healthcare services to every patient, every time. Our core values are Quality, Service, Stewardship, Teamwork and Innovation.

For more details, please visit us online at and follow us on Facebook at

About the Auryon Atherectomy System

The Auryon Atherectomy System uses innovative technology to deliver powerful treatment of arterial occlusions. The Auryon Atherectomy System is the first laser atherectomy system to efficiently treat any lesion type, any lesion length, at any lesion location, with minimal impact on vessel walls1,4-6. The Auryon Atherectomy System uses solid-state laser technology for the treatment of PAD and is FDA-cleared with an indication for treatment, including atherectomy of infrainguinal stenoses and occlusions, including ISR1,2. The Auryon System’s targeted biological reactions minimize the risk of perforation and preserve the ability to vaporize lesions without thermal ablation7. The Auryon System uses a 355nm wavelength laser platform, which enables the use of longer wavelengths and shorter pulses to produce a groundbreaking delivery of short UV laser pulses2. For more information, please visit For important risk information, visit

About AngioDynamics, Inc.
AngioDynamics is a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients. The Company’s innovative technologies and devices are chosen by talented physicians in fast-growing healthcare markets to treat unmet patient needs. For more information, visit


  1. 1.Rundback J, Chandra P, Brodmann M, Weinstock B, Sedillo G, Cawich I, et al. Novel laser-based catheter for peripheral atherectomy: 6-month results from the Eximo Medical B-LaserTM IDE study. Catheter Cardiovasc Interv. 2019;1-8.
  2. Auryon System Indications for Use
  3. Herzog A, Bogdan S, Glikson M, Ishaaya AA, Love C. Selective tissue ablation using laser radiation at 355 nm in lead extraction by a hybrid catheter; a preliminary report. Lasers Surg Med. 2016;48(3):281-287.
  4. Vogel A, Venugopalan V. Mechanisms of pulsed laser ablation of biological tissues. Chem Rev. 2003;103(2):577-644.
  5. Akkus NI, Abdulbaki A, Jimenez E, Tandon N. Atherectomy devices: technology update. Med Devices (Auckl). 2015;8:1-10.
  6. Taylor RS, Higginson LAJ, Leopold KE. Dependence of the XeCl laser cut rate of plaque on the degree of calcification, laser fluence, and optical pulse duration. Lasers Surg Med. 1990;10(5):414-419.


Latest News

CIS Staff

Written by CIS Staff